SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges.


Journal

The Journal of general virology
ISSN: 1465-2099
Titre abrégé: J Gen Virol
Pays: England
ID NLM: 0077340

Informations de publication

Date de publication:
04 2022
Historique:
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 7 4 2022
Statut: ppublish

Résumé

Following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in PR China in late 2019 a number of variants have emerged, with two of these - alpha and delta - subsequently growing to global prevalence. One characteristic of these variants are changes within the spike protein, in particular the receptor-binding domain (RBD). From a public health perspective, these changes have important implications for increased transmissibility and immune escape; however, their presence could also modify the intrinsic host range of the virus. Using viral pseudotyping, we examined whether the variants of concern (VOCs) alpha, beta, gamma and delta have differing host angiotensin-converting enzyme 2 (ACE2) receptor usage patterns, focusing on a range of relevant mammalian ACE2 proteins. All four VOCs were able to overcome a previous restriction for mouse ACE2, with demonstrable differences also seen for individual VOCs with rat, ferret or civet ACE2 receptors, changes that we subsequently attributed to N501Y and E484K substitutions within the spike RBD.

Identifiants

pubmed: 35377298
doi: 10.1099/jgv.0.001735
doi:

Substances chimiques

Peptidyl-Dipeptidase A EC 3.4.15.1
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/V036750/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W005611/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007038
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007034
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/COV07001
Pays : United Kingdom

Auteurs

Nazia Thakur (N)

The Pirbright Institute, Guildford, Surrey, GU24 0NF, UK.
Nuffield Department of Medicine, The Jenner Institute, Oxford, OX3 7DQ, UK.

Giulia Gallo (G)

The Pirbright Institute, Guildford, Surrey, GU24 0NF, UK.

Joseph Newman (J)

The Pirbright Institute, Guildford, Surrey, GU24 0NF, UK.

Thomas P Peacock (TP)

Department of Infectious Disease, Imperial College - London, W2 1PG, UK.

Luca Biasetti (L)

School of Psychology and Neuroscience, University of Sussex, Falmer, BN1 9QH, UK.

Catherine N Hall (CN)

School of Psychology and Neuroscience, University of Sussex, Falmer, BN1 9QH, UK.

Edward Wright (E)

Viral Pseudotype Unit, School of Life Sciences, University of Sussex, Falmer, BN1 9QG, UK.

Wendy Barclay (W)

Department of Infectious Disease, Imperial College - London, W2 1PG, UK.

Dalan Bailey (D)

The Pirbright Institute, Guildford, Surrey, GU24 0NF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH